Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Glaxo, Genmab report phase III ofatumumab study did not meet primary endpoint
Glaxo, Genmab report phase III ofatumumab study did not meet primary endpoint
Glaxo, Genmab report phase III ofatumumab study did not meet primary endpoint
Submitted by
admin
on May 19, 2014 - 3:17pm
Source:
The Fly on the Wall
News Tags:
GSK
Genmab
ofatumumab
large B-cell lymphoma
Headline:
Glaxo, Genmab report phase III ofatumumab study did not meet primary endpoint
Do Not Allow Advertisers to Use My Personal information
